Alison Morrow: Emmy-Winning Journalist FIRED For Refusing To Censor Interview With Doctor, Launches Lawsuit Against Washington State – Ask Dr. Drew – Ep 431

Ask Dr. Drew

Emmy-winning journalist Alison Morrow was fired by Washington state authorities after she defied their orders to censor an interview with Dr. Aaron Kheriaty – an act he calls “a clear violation by a government employer of an employee’s First Amendment free speech rights.”

Reclaim The Net reports that with the “Silent Majority Foundation, Morrow has filed a lawsuit against the Washington State Department of Natural Resources (DNR) and its top officials, citing wrongful termination.”

“I was told I could never interview Dr Kheriaty (or anyone with ideas like his) ever again if I wanted to keep my job… when I refused, I was fired,” writes Alison. “And I would do it all over again.”

Alison Morrow (AKA Alison Westover) is an Emmy Award-winning journalist and media analyst with over a decade of experience in television news. A former FOX News producer and environmental reporter for NBC Seattle (KING TV), she holds a Master of Divinity from Boston University specializing in Psychology & Counseling. Morrow has earned an Associated Press Award and the Sigma Delta Chi Award for Excellence in Journalism. She currently hosts podcasts focused on environmental issues and media analysis, particularly covering endangered Southern Resident killer whales. Find more at https://alisonmorrowmedia.com and follow her at https://x.com/alisonmorrowTV

Pete Serrano is Director and General Counsel for Silent Majority Foundation. Learn more at https://silentmajorityfoundation.org

Dr. Stephanie Venn-Watson is a co-founder of Seraphina Therapeutics. She holds a Doctor of Veterinary Medicine from Tufts University, a Master of Public Health from Emory University, and completed a National Research Council Associateship with the Armed Forces Medical Intelligence Center. As a Technical Agent for DARPA and researcher with the U.S. Navy Marine Mammal Program, she discovered C15:0’s role in preventing Cellular Fragility Syndrome. This led her to co-found Seraphina Therapeutics, developing the fatty15 supplement. Find more at https://drdrew.com/fatty15

「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at https://drdrew.com/sponsors

• CAPSADYN - Get pain relief with the power of capsaicin from chili peppers – without the burning! Capsadyn's proprietary formulation for joint & muscle pain contains no NSAIDs, opioids, anesthetics, or steroids. Try it for 15% off at https://drdrew.com/capsadyn

• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15

• CHECK GENETICS - Your DNA is the key to discovering the RIGHT medication for you. Escape the big pharma cycle and understand your genetic medication blueprint with pharmacogenetic testing. Save $200 with code DRDREW at https://drdrew.com/check

• PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley

• THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew

「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health.

「 ABOUT THE SHOW 」

Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment.

Learn more about your ad choices. Visit megaphone.fm/adchoices